Learn about the global cell and gene therapy market through The Business Research Company, which provides information on cell and gene therapy market size, cell and gene therapy market drivers and restraints, cell and gene therapy market players, the COVID-19 impact on the cell and gene therapy market, and more.

The global cell and gene therapy market is expected to grow from $6.58 billion in 2021 to $8.57 billion in 2022 at a compound annual growth rate (CAGR) of 30.2%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The gene and cell therapy market is expected to reach $21.33 billion in 2026 at a CAGR of 25.6%.

Steady investment and consolidation in cell and gene therapies contributed to the growth of the cell and gene therapy (CGT) market.

Request A Sample For The Global Cell And Gene Therapy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3472&type=smp

The cell and gene therapy market consist of sales of cell and gene therapies by entities (organizations, sole traders and partnerships) that develop cell and gene therapies. Cell therapy refers to the transfer of intact, live cells that are originated from autologous or allogenic sources and gene therapy refers to the introduction, removal, or change in the genome for treating diseases. The market consists of revenue generated by the companies developing cell and gene therapy products by the sales of these products.

Global Cell And Gene Therapy Market Segments Include:

By Product: Cell Therapy, Gene Therapy

By Application: Oncology, Dermatology, Musculoskeletal, Others

By End-User: Hospitals, Ambulatory Surgical Centres, Cancer Care Centres, Wound Care Centres, Others

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Chimeric antigen receptor (CAR) T-cell therapy is shaping the cell and gene therapy (CGT) market. CAR T-cell therapy is a combination of cell and gene therapy in which T cells are collected from the patient’s blood and are genetically engineered to produce modified receptors at their surface, known as chimeric antigen receptors. These modified T cells with special structures (receptors) are reinfused into the patient. Then, the modified receptors of T cell help in targeting the surface antigen of the cancer cell that ultimately results in the killing of tumor cells in patients.

TBRC’s cell and gene therapy market report covers:

Major Market Players: Gilead Sciences, Bristol-Myers Squibb, Novartis AG, Amgen, Merck, Organogenesis Holdings, Dendreon, Vericel, Bluebird Bio, and Fibrocell Science.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)

The Cell And Gene Therapy Global Market Report 2022–Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides cell and gene therapy market overviews, analyses and forecasts market size, share, cell and gene therapy market players, cell and gene therapy market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s cell and gene therapy market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:

Gene Editing Global Market Report 2022

Stem Cell/Cord Blood Banking Global Market Report 2022

Cell Based Assays Global Market Report 2022

Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: